Singh R, White D, Romano G, Osenda E, Allen S, Dunstan M, Elangovan R, Jourdan I, Rockall T, Scala A
Royal Surrey NHS Foundation Trust, UK.
Ann R Coll Surg Engl. 2024 Jan;106(1):13-18. doi: 10.1308/rcsann.2022.0156. Epub 2023 Feb 7.
Colorectal cancer survivors have many problems affecting their quality of life (QOL). Traditional follow-up focuses on the detection of recurrence rather than QOL. Efforts are being made to assess patient-reported outcomes (PROMS) more formally. Such changes may enable patients to consider QOL factors when deciding on treatment.
Patients who underwent laparoscopic surgery for rectal cancer between 2005 and 2015 at a single institution were identified and sent European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 and QLQ-CR29 QOL questionnaires. QOL and the impact of radiotherapy, chemotherapy and formation of end colostomy were assessed.
Some 141 patients were identified: 12 died and 118 (83.7%) responded, of whom 101 completed the questionnaires and 17 declined to participate; 11 were lost to follow-up. Mean age was 67 years, median follow-up was 58 months. Median QOL score was 6 (maximum 7) and 4.5% of patients reported a poor QOL score (<4). Significant rectal/perianal pain, sexual dysfunction and urinary symptoms were reported in 3.6%, 10.9% and 2.7% of respondents, respectively. Significant differences between treatment groups were uncommon. All cohorts reported similar QOL, functional and symptom scores.
These results compare favourably with the published data. Future studies may benefit from baseline assessment to better assess treatment impact, prescient in an increasingly elderly and comorbid population. This paper establishes that good PROMs are achievable with laparoscopic surgery for rectal cancer. It identifies limited differences in QOL between treatment modalities. Restoration of intestinal continuity and end colostomy result in similar QOL. This may address common concerns regarding stomata, sexual function and low anterior resection syndrome in this cohort.
结直肠癌幸存者存在许多影响其生活质量(QOL)的问题。传统的随访侧重于复发的检测而非生活质量。目前正在努力更正式地评估患者报告的结局(PROMS)。这些变化可能使患者在决定治疗方案时能够考虑生活质量因素。
确定2005年至2015年期间在单一机构接受直肠癌腹腔镜手术的患者,并向其发送欧洲癌症研究与治疗组织(EORTC)QLQ-C30和QLQ-CR29生活质量问卷。评估生活质量以及放疗、化疗和末端结肠造口术形成的影响。
共确定了约141例患者:12例死亡,118例(83.7%)作出回应,其中101例完成问卷,17例拒绝参与;11例失访。平均年龄为67岁,中位随访时间为58个月。生活质量中位数评分为6(满分7),4.5%的患者报告生活质量评分较差(<4)。分别有3.6%、10.9%和2.7%的受访者报告有明显的直肠/肛周疼痛、性功能障碍和泌尿系统症状。治疗组之间的显著差异并不常见。所有队列的生活质量、功能和症状评分相似。
这些结果与已发表的数据相比具有优势。未来的研究可能会受益于基线评估,以便更好地评估治疗影响,这在老年和合并症患者日益增多的人群中很有先见之明。本文证实直肠癌腹腔镜手术可实现良好的患者报告结局。它确定了不同治疗方式之间生活质量的有限差异。肠道连续性的恢复和末端结肠造口术导致相似的生活质量。这可能解决了该队列中关于造口、性功能和低位前切除综合征的常见问题。